iifl-logo-icon 1

Lupin Ltd Share Price

2,270.9
(0.85%)
Sep 17, 2024|02:34:58 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2,259.85
  • Day's High2,286
  • 52 Wk High2,312
  • Prev. Close2,251.85
  • Day's Low2,251.05
  • 52 Wk Low 1,091.5
  • Turnover (lac)14,801.13
  • P/E37.52
  • Face Value2
  • Book Value471.18
  • EPS60.03
  • Mkt. Cap (Cr.)1,03,584.25
  • Div. Yield0.35
View All Historical Data
Loading...
  • Open1,812.9
  • Day's High1,823.4
  • Spot1,798
  • Prev. Close1,817
  • Day's Low1,799.45
  • ViewShort BuildUp
  • Market Lot425
  • OI(Chg %)10,57,825 (29.8%)
  • Roll Over%1.66
  • Roll Cost0.83
  • Traded Vol.44,75,675 (21.97%)
View More Futures

Lupin Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

2,259.85

Prev. Close

2,251.85

Turnover(Lac.)

14,801.13

Day's High

2,286

Day's Low

2,251.05

52 Week's High

2,312

52 Week's Low

1,091.5

Book Value

471.18

Face Value

2

Mkt Cap (₹ Cr.)

1,03,584.25

P/E

37.52

EPS

60.03

Divi. Yield

0.35

Lupin Ltd Corporate Action

9 Jul 2024

12:00 AM

AGM

Announcement Date: 09 Jul, 2024

arrow

6 May 2024

12:00 AM

Dividend

Dividend Amount: 8

Record Date: 16 Jul, 2024

arrow

23 Jul 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Lupin Ltd NEWS AND UPDATE

Lupin Q1 Net Profit Jumps 77%, Shares Rise 5%
7 Aug 2024|10:44 AM

Lupin Limited reports a 77% increase in Q1 net profit to ₹801.3 crores, with total sales up 16.3%.

Read More
Top 10 stocks for today – 7th August 2024
7 Aug 2024|08:16 AM

Here are some of the stocks that may see significant price movement today: Tata Power, Chambal Fertilisers, Cummins India, etc.

Read More
Top 10 stocks for today – 06th August 2024
6 Aug 2024|09:11 AM

Here are some of the stocks that may see significant price movement today: Adani Energy Solutions, Bharti Airtel, Bharti Hexacom, etc.

Read More
Lupin sells US women’s health business for $84 million
16 Jul 2024|11:15 AM

According to the terms of the agreement, Lupin may receive up to $84 million in total payment based on future dependent milestones.

Read More
Top 10 stocks for today - 16th July, 2024
16 Jul 2024|08:47 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Lupin Ltd SHAREHOLDING SNAPSHOT

17 Sep, 2024|04:20 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.28%

Foreign: 0.28%

Indian: 46.70%

Non-Promoter- 46.11%

Institutions: 46.10%

Non-Institutions: 6.91%

Custodian: 0.00%

Share Price

Lupin Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

91.22

91

90.9

90.79

Preference Capital

0

0

0

0

Reserves

20,511.87

18,320.86

18,059.29

18,474.78

Net Worth

20,603.09

18,411.86

18,150.19

18,565.57

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

11,771.67

11,055.93

11,025.66

10,080.58

yoy growth (%)

6.47

0.27

9.37

-20.16

Raw materials

-4,467.26

-4,182.31

-4,207.27

-3,474.35

As % of sales

37.94

37.82

38.15

34.46

Employee costs

-1,918.16

-1,695.86

-1,703.22

-1,441.64

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

-161.53

1,629.7

1,811.46

1,793.93

Depreciation

-514.19

-502.83

-518.75

-389.81

Tax paid

-27.17

-371.08

-324.7

-449.27

Working capital

-135.75

-894.67

-203.16

1,003.92

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

6.47

0.27

9.37

-20.16

Op profit growth

-89.76

7.15

-8.54

-53.5

EBIT growth

-105.27

-10.39

2.01

-56.58

Net profit growth

-114.99

72.99

-45.89

-57.19

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

19,656.34

16,269.98

16,192.79

14,926.99

15,142.8

Excise Duty

0

0

0

0

0

Net Sales

19,656.34

16,269.98

16,192.79

14,926.99

15,142.8

Other Operating Income

354.48

371.68

212.69

235.97

231.96

Other Income

120.17

73.36

142.05

137.62

617.8

Lupin Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,866.1

160.64,46,984.11237.820.724,409.7498.75

Divis Laboratories Ltd

DIVISLAB

5,452.2

87.571,45,452.894300.552,063507.93

Cipla Ltd

CIPLA

1,671.8

33.751,34,027.851,055.940.783,752.25346.39

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,453.25

77.741,16,844.734690.812,394201.77

Zydus Lifesciences Ltd

ZYDUSLIFE

1,110.95

25.71,12,260.51,700.80.274,035.4156.19

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Lupin Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

M D Gupta

Managing Director

Nilesh Deshbandhu Gupta.

Director & Chief Executive Off

Vinita Gupta

Company Sec. & Compli. Officer

R V Satam

Independent Director

Jean-Luc Belingard

Executive Director & CFO

Ramesh Swaminathan

Independent Director

Mark D McDade

Independent Director

K B S Anand

Independent Director

Punita Kumar Sinha

Independent Director

Jeffrey Kindler

Independent Director

Alfonso Zulueta

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar. In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd. In the year 1991, they initiated production of Injectable cephalosporin (bulk and dosages) at Mandideep. In the year 1992, the company set up Fermentation Plant at Tarapur, Maharashtra. Also, Sterile Plant for injectable Cephalosporins (bulk) was commissioned at Mandideep.In the year 2001, Lupin Laboratories Ltd was amalgamated with the company and the name was changed to Lupin Ltd. They commenced supply of Cephalosporin bulk actives to their alliance partners in the US. Also, they commissioned a state of the art US FDA approvable oral cephalosporin bulk active plant. In the year 2002, the company commissioned the new Anti-TB facility at Aurangabad. In the year 2003, the
Read More

Company FAQs

What is the Lupin Ltd share price today?

Down Arrow

The Lupin Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹2270.9 today.

What is the Market Cap of Lupin Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lupin Ltd is ₹103584.25 Cr. as of 17 Sep ‘24

What is the PE and PB ratio of Lupin Ltd?

Down Arrow

The PE and PB ratios of Lupin Ltd is 37.52 and 4.99 as of 17 Sep ‘24

What is the 52 Week High and Low of Lupin Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Lupin Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Lupin Ltd is ₹1091.5 and ₹2312 as of 17 Sep ‘24

What is the CAGR of Lupin Ltd?

Down Arrow

Lupin Ltd's CAGR for 5 Years at 23.97%, 3 Years at 32.50%, 1 Year at 97.61%, 6 Month at 39.49%, 3 Month at 42.39% and 1 Month at 7.95%.

What is the shareholding pattern of Lupin Ltd?

Down Arrow

The shareholding pattern of Lupin Ltd is as follows:
Promoters - 46.98 %
Institutions - 46.10 %
Public - 6.92 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp